Page 102 - Characterization of genetic neurodevelopmental disorders at adult age, with a focus on 22q11.2 deletion syndrome - Emma Boersma

Chapter 2
sReferences
1. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline
for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
2. Lipton J, Rivkin MJ. 16p11.2-related paroxysmal kinesigenic dyskinesia and dopa-responsive
parkinsonism in a child. Neurology. 2009;73(6):479-480. doi:http://dx.doi.org/10.1212/
WNL.0b013e3181b16393
3. Roeben B, Blum D, Gabriel H, Synofzik M. Atypical parkinsonism with severely reduced
striatal dopamine uptake associated with a 16p11.2 duplication syndrome. J Neurol. Mar
2019;266(3):775-776. doi:10.1007/s00415-019-09182-7
4. Baudoin H, Jacquette A, Grabli D, Whalen S, Lenglet T. The co-occurence of early onset
Parkinson’s disease (PD) and 22q11.2 deletion syndrome (22qDS): More than a coincidence.
Movement Disorders. 2010;25(SUPPL. 2):S468-S469. 14th International Congress of Parkinson’s
Disease and Movement Disorders. Buenos Aires Argentina.(var.pagings). doi:http://dx.doi.
org/10.1002/mds.23162
5. Booij J, van Amelsvoort T, Boot E. Co-occurrence of early-onset Parkinson disease and
22q11.2 deletion syndrome: Potential role for dopamine transporter imaging. Am J Med Genet
A. Nov 2010;152a(11):2937-8. doi:10.1002/ajmg.a.33665
6. Boot E, Butcher NJ, van Amelsvoort TA, et al. Movement disorders and other motor abnormalities
in adults with 22q11.2 deletion syndrome. Am J Med Genet A. Mar 2015;167a(3):639-45.
doi:10.1002/ajmg.a.36928
7. Gambardella S, Ferese R, Scala S, et al. Mitochondrial Serine Protease HTRA2 p.G399S in a
Female with Di George Syndrome and Parkinson’s Disease. Parkinsons Dis. 2018;2018:5651435.
doi:10.1155/2018/5651435
8. Hu ZX, Lu XD, Lou DN, et al. A case report of a Chinese patient with 22q11.2 deletion
accompanied with EOPD, severe dystonia and hypocalcemia. Clinical Parkinsonism and Related
Disorders. 2019;1:72-73. doi:http://dx.doi.org/10.1016/j.prdoa.2019.07.002
9. Krahn LE, Maraganore DM, Michels VV. Childhood-onset schizophrenia associated with
parkinsonism in a patient with a microdeletion of chromosome 22. Mayo Clinic Proceedings.
1998;73(10):956-959. doi:http://dx.doi.org/10.4065/73.10.956
10. Mills KA, Reich SG. Early onset parkinson’s disease and chromosome 22q11 deletion: Case
report. Annals of Neurology. 2016;80(Supplement 20):S94. 141st Annual Meeting of the
American Neurological Association, ANA 2016. United States. doi:http://dx.doi.org/10.1002/
ana.24759
11. Moreira F, Bras A, Lopes JR, Januario C. Parkinson’s disease with hypocalcaemia: adult
presentation of 22q11.2 deletion syndrome. BMJ Case Rep. Mar 22 2018;2018doi:10.1136/
bcr-2017-223751
12. Oki M, Hori S, Asayama S, Wate R, Kaneko S, Kusaka H. Early-onset Parkinson’s Disease
Associated with Chromosome 22q11.2 Deletion Syndrome. Intern Med. 2016;55(3):303-5.
doi:10.2169/internalmedicine.55.5485
13. Pollard R, Hannan M, Tanabe J, Berman BD. Early-onset Parkinson disease leading to diagnosis
of 22q11.2 deletion syndrome. Parkinsonism Relat Disord. Apr 2016;25:110-1. doi:10.1016/j.
parkreldis.2016.01.027
14. Rehman AF, Dhamija R, Williams ES, Barrett MJ. 22q11.2 deletion syndrome presenting with
early-onset Parkinson’s disease. Mov Disord. Aug 2015;30(9):1289-90. doi:10.1002/mds.26305
15. Verhoeven WMA, Egger JIM, De Leeuw N. Psychopathology and differentiated
psychopharmacological treatment strategy in subtypes of 22q11.2 deletion syndrome.
European Archives of Psychiatry and Clinical Neuroscience. 2017;267(1 Supplement 1):S64-S65.
6th European Conference on Schizophrenia Research: Advancing Research - Promoting
Recovery. Germany. doi:http://dx.doi.org/10.1007/s00406-017-0824-8
16. Zaleski C, Bassett AS, Tam K, Shugar AL, Chow EW, McPherson E. The co-occurrence
of early onset Parkinson disease and 22q11.2 deletion syndrome. Am J Med Genet A. Mar
2009;149a(3):525-8. doi:10.1002/ajmg.a.32650
100